PEBP1 and neoplasm: In line with the concept of RKIP contributing to tumor suppression via modulating immune responses, RKIP inhibits NFκB activation via downregulating IκB kinase (IKK) [77]; NFκB is a critical transcription factor that regulates immunity [78,79] and promotes tumorigenesis [80].